Zobrazeno 1 - 2
of 2
pro vyhledávání: '"E M Maor"'
Autor:
R Raphael, N M Makmal, N S Silbermintz, K F Faierstein, C M Moeller, M C Canetti, E M Maor, R F Kuperstein, I H Hai, A B Butnaru, D O Oren, V G Guetta, P F Fefer
Publikováno v:
European Heart Journal. 43
Introduction The COAPT trial established the benefit of trans-catheter edge-to-edge mitral valve repair (TEER) for patients with symptomatic secondary mitral regurgitation (MR). However, patients with severe LV dilatation were excluded from this stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9c4a87407fda88e63e479536c969ef7
https://doi.org/10.1093/eurheartj/ehac544.2125
https://doi.org/10.1093/eurheartj/ehac544.2125
Autor:
A G Goldman, E R Raschi, T Y Cukierman-Yaffe, R D Dankner, R S Shouval, M D Shechter, I B Z Ben-Zvi, E M Maor
Publikováno v:
European Heart Journal. 42
Background Initial genetic and biological studies indicated an association between proprotein-convertase subtilisin/kexin type 9 inhibitors (PCSK9i) and hyperglycemic disorders. However, subsequent clinical trials yielded inconsistent results, and re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4cdaff4b236ca732cb45ab778d54836e
https://doi.org/10.1093/eurheartj/ehab724.2934
https://doi.org/10.1093/eurheartj/ehab724.2934